Putney Launches Generic Ketamine, Other Products In Pipeline



Published:

Putney Inc. of Portland, Maine, reported today that the U.S. Food and Drug Administration’s Center of Veterinary Medicine has approved its generic ketamine hydrochloride for injection.

Additional launches of generic pet medications are to follow, including analgesics, anti-infectives, anesthetics, sedatives, dermatologicals and parasiticides, according to Anthony Lucas, BVMS, Ph.D., senior director of product development.

Today’s launch follows the company’s carprofen caplet introduction in 2009. Since then, Putney has advanced its research and development pipeline of generic pet pharmaceutical products for submission to CVM.

These rollouts are just the beginning, Dr. Lucas said.

Putney’s ketamine hydrochloride, which comes in 10 mL vials (100 mg/mL), is indicated for use in cats for restraint or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal muscle relaxation, according to the product’s label. It may also be used in subhuman primates for restraint.

Distributors currently carrying the product include D-V Medical Supply Inc., First Veterinary Supply, PCI Animal Health, Victor Medical Co. and Webster Veterinary.

<Home>

 

Edit Module
Edit ModuleShow Tags

Archive »Read More

Abaxis Enjoys Huge Jump in Sales, Profit

Partnering with distributors paid off for Abaxis, while competitor Idexx saw a small revenue dip while moving to direct sales.

Tag Maker PetHub Adds Patient Records Feature

A hospital’s electronic records may be shared to help identity lost pets wearing a PetHub tag.

Do You Know a Hero Vet or Vet Tech?

The American Humane Association is accepting nominations until March 13 as part of a nationwide contest.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module